Subcutaneous Formulation Of ORENCIA® (Abatacept) Approved By European Commission

Bristol-Myers Squibb have announced that the European Commission has granted marketing authorisation for the subcutaneous formulation of ORENCIA® (abatacept), in combination with methotrexate (MTX), for the treatment of adults with moderate to severe active rheumatoid arthritis (RA).

Cardiology: Heart Attack Mortality Risk Greater For People With Schizophrenia

The risk of death resulting from heart attack is higher in people with schizophrenia than in the general public, according to scientists at the Centre for Addiction and Mental Health (CAMH) and the Institute for Clinical Evaluative Sciences (ICES).

MRI: Supposed Benign Condition Shown to Alter Brain Function in the Elderly

Researchers are reporting that a common condition called leukoaraiosis, comprised of tiny areas in the brain that have been deprived of oxygen and appear as bright white dots on magnetic resonance imaging (MRI) scans, is not a harmless part of the aging process, but instead a disease that changes brain function in the elderly.

New Maryland Law Enables Consumers To Select Qualified Physicians

A new Maryland law effective today requires physicians who publicize board certification to announce their certifying board as well as their speciality.

Imaging IT: Healthcare Organizations Utilize Enterprise Services to Fast-Track Health IT Purchases

New enterprise services help healthcare providers predict operational and information technology (IT) costs and control ongoing costs while deploying enterprise-wide health IT systems.

Ultrasound: Partnership to Offer Advanced Needle Guidance technology

New needle guidance solution helps make central venous catheter procedures “point-and-shoot” simple to improve care quality and reduce healthcare costs.

Nuclear Medicine: The preoperative visualization of SLN with SPECT/CT is technically feasible and facilitates the detection of additional positive SLNs.

Preoperative three-dimensional (3D) visualization of sentinel lymph nodes (SLNs) used with single-photon emission computed tomography/computed tomography (SPECT/CT) imaging was associated with a higher rate of identification of positive SLNs and a higher rate of disease-free survival among patients with melanoma, according to new findings.